Cargando…

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

Intrinsic and acquired anti-HER2 resistance remains a major hurdle for treating HER2-positive breast cancer. Using genome-wide CRISPR/Cas9 screening in vitro and in vivo, we identify FGFR4 as an essential gene following anti-HER2 treatment. FGFR4 inhibition enhances susceptibility to anti-HER2 thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Yutian, Zheng, Shaoquan, Xie, Xinhua, Ye, Feng, Hu, Xiaoqian, Tian, Zhi, Yan, Shu-Mei, Yang, Lu, Kong, Yanan, Tang, Yuhui, Tian, Wenwen, Xie, Jindong, Deng, Xinpei, Zeng, Yan, Chen, Zhe-Sheng, Tang, Hailin, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106694/ https://www.ncbi.nlm.nih.gov/pubmed/35562334 http://dx.doi.org/10.1038/s41467-022-30217-7

Ejemplares similares

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

The Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis
por: Zou, Yutian, et al.
Publicado: (2019)

Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration
por: Tian, Wenwen, et al.
Publicado: (2023)

The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
por: Xie, Jindong, et al.
Publicado: (2022)

Heterogeneous PD-L1 expression in metastases impacts immunotherapy response
por: Hu, Xiaoqian, et al.
Publicado: (2023)

Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer
por: Zou, Yutian, et al.
Publicado: (2022)

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
por: Zou, Yutian, et al.
Publicado: (2022)

Advances in artificial intelligence to predict cancer immunotherapy efficacy
por: Xie, Jindong, et al.
Publicado: (2023)

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2022)

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
por: Tian, Wenwen, et al.
Publicado: (2023)

Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
por: Xie, Jindong, et al.
Publicado: (2022)

Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A multidimensional analysis
por: Zou, Yutian, et al.
Publicado: (2020)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

Diagnostic and prognostic value of circular RNA CDR1as/ciRS‐7 for solid tumours: A systematic review and meta‐analysis
por: Zou, Yutian, et al.
Publicado: (2020)

Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study
por: Xiao, Weikai, et al.
Publicado: (2018)

The biogenesis, function and clinical significance of circular RNAs in breast cancer
por: Zeng, Yan, et al.
Publicado: (2022)

Recent advances in exosome-based immunotherapy applied to cancer
por: Xie, Jindong, et al.
Publicado: (2023)

Is Acupuncture an Ideal Adjunctive Treatment for Cancer-Related Fatigue? Comment on Choi et al. Acupuncture for Managing Cancer-Related Fatigue in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Cancers 2022, 14, 4419
por: Hu, Xiaoqian, et al.
Publicado: (2022)

Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature
por: Tang, Yuhui, et al.
Publicado: (2022)

Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
por: Xiao, Weikai, et al.
Publicado: (2018)

Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
por: Zou, Yutian, et al.
Publicado: (2020)

The Impact of Preoperative Radiomics Signature on the Survival of Breast Cancer Patients With Residual Tumors After NAC
por: Zhang, Ling, et al.
Publicado: (2021)

Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study
por: Zheng, Shaoquan, et al.
Publicado: (2023)

Incidence and Survival Outcomes of Breast Cancer with Synchronous Hepatic Metastases: A Population-Based Study
por: Xiao, Weikai, et al.
Publicado: (2018)

circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer
por: Ye, Feng, et al.
Publicado: (2019)

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
por: Liu, Peng, et al.
Publicado: (2019)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study
por: Yu, Ping, et al.
Publicado: (2020)

SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
por: Xiao, Weikai, et al.
Publicado: (2020)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

Correction to: Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Breast‐conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population‐based study
por: Yu, Ping, et al.
Publicado: (2020)

HSPB1 as a Novel Regulator of Ferroptotic Cancer Cell Death
por: Sun, Xiaofang, et al.
Publicado: (2015)

Melatonin Regulates Breast Cancer Progression by the lnc010561/miR-30/FKBP3 Axis
por: Liu, Peng, et al.
Publicado: (2019)

Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation
por: Liu, Peng, et al.
Publicado: (2023)

Multifunctional Nanomaterials for Ferroptotic Cancer Therapy
por: Shi, Zhiyuan, et al.
Publicado: (2022)

Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer
por: Xie, Xinhua, et al.
Publicado: (2018)

Single cell RNA-seq analysis identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an anti-ferroptotic target in osteoarthritis
por: Lv, Zhongyang, et al.
Publicado: (2022)

A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hvlbbhoi1ee2j9svr524q7se41